<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="432">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04425720</url>
  </required_header>
  <id_info>
    <org_study_id>2020-11824</org_study_id>
    <nct_id>NCT04425720</nct_id>
  </id_info>
  <brief_title>Use of Remote Monitoring for COVID-19 Patient</brief_title>
  <acronym>RPM</acronym>
  <official_title>Use of Remote Patient Monitoring (RPM) Platform for COVID-19 Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The central hypothesis motivating this study is that remote patient monitoring (RPM) of
      infectious disease patients can efficiently facilitate self-isolation. Additionally, RPM can
      assist in more rapid identification of patients at risk, facilitate detection of patient
      deterioration, and enable early interventions, all of which play a vital role in resource
      utilization and outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim-I To develop and test a clinical care pathway that can be utilized in similar epidemic
      conditions in the future. To study this aim, the investigators will be using the COVID-19
      medical surge as a condition to evaluate the framework of delivering care through remote
      patient monitoring. The success of this care delivery model will be evaluated on ease of
      model implementation, patient satisfaction, clinical outcomes, and the utilization of shared
      decision making.

      Aim-II To evaluate remote patient monitoring for appropriate resource utilization in epidemic
      and pandemic conditions. To evaluate this aim, the investigators plan to compare the
      emergency department (ED) visits and in-patient admission of patients with and without
      wearable remote patient monitoring devices. Additionally, the investigators will compare the
      number of patients that required critical interventions (mechanical ventilation and ECMO)
      during the hospital stay.

      Aim III To evaluate the utilization of wearable technology for upfront predictions of
      patients that would require in-patient admissions. To evaluate this aim, patients who are
      diagnosed with COVID-19 and are undergoing self-quarantine will be closely monitored using a
      wearable device, and shared-clinical decisions will be made based on the monitored data and
      patient diary. The comparison group will be patients undergoing routine standard of care at
      the hospital. ED visits, in-patient hospital admissions, and patient satisfaction will be the
      outcome measures compared between the two groups.

      Aim IV To evaluate the association between early identification of critical, abnormal vital
      signs and the prevention of serious adverse events. To evaluate this aim, patients in the
      monitored group and non-monitored group will be compared for ED visits, in-patient
      admissions, length of hospital stay, and serious adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 31, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Monitored versus Non-Monitored in-patient admission</measure>
    <time_frame>14 days</time_frame>
    <description>compare the number of in-patient admissions between the monitored and non-monitored patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emergency Department Visits</measure>
    <time_frame>14 days</time_frame>
    <description>compare the number of Emergency Department visits</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Length of stay</measure>
    <time_frame>14 days</time_frame>
    <description>Length of stay of subject if hospitalized</description>
  </primary_outcome>
  <primary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>14 days</time_frame>
    <description>Survey given to patient to ask about satisfaction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the incidence of mechanical ventilation and ECMO</measure>
    <time_frame>14 days</time_frame>
    <description>How often does a subject end up getting mechanical ventilation or ECMO</description>
  </primary_outcome>
  <primary_outcome>
    <measure>serious adverse events</measure>
    <time_frame>14 days</time_frame>
    <description>events requiring extended hospital stay</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>COVID</condition>
  <arm_group>
    <arm_group_label>Standard Of Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients without wearable monitoring technology undergoing routine standard of care at the hospital.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Monitored</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who are diagnosed with COVID-19 and are undergoing self-quarantine will be closely monitored using a wearable device, and shared-clinical decisions will be made based on the monitored data and patient diary</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LifeSignals Biosensor 1AX*</intervention_name>
    <description>Shared-clinical decisions will be made based on the monitored data and patient diary. Two devices will be used to monitor data, LifeSignals Biosensor 1AX* and a pulse oximeter.</description>
    <arm_group_label>Monitored</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of Care</intervention_name>
    <description>This group will be treated based on standard of care at our institution.</description>
    <arm_group_label>Standard Of Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Covid-19 positive patient

          -  Does not require in-patient admission

        Exclusion Criteria:

          -  Allergic to sensor patch

          -  Has implanted pacemaker

          -  Has excessive sweating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan Leff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jonathan Leff, MD</last_name>
    <phone>7189204316</phone>
    <email>jleff@montefiore.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Singh Nair, PhD</last_name>
    <phone>7189205932</phone>
    <email>sinair@montefiore.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26. Review. Erratum in: Int J Surg. 2020 May;77:217.</citation>
    <PMID>32112977</PMID>
  </reference>
  <reference>
    <citation>Wilder-Smith A, Chiew CJ, Lee VJ. Can we contain the COVID-19 outbreak with the same measures as for SARS? Lancet Infect Dis. 2020 May;20(5):e102-e107. doi: 10.1016/S1473-3099(20)30129-8. Epub 2020 Mar 5. Review.</citation>
    <PMID>32145768</PMID>
  </reference>
  <reference>
    <citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.</citation>
    <PMID>31986264</PMID>
  </reference>
  <reference>
    <citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.</citation>
    <PMID>32031570</PMID>
  </reference>
  <reference>
    <citation>Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li CH, Li GC, Liu HG. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020 May 5;133(9):1025-1031. doi: 10.1097/CM9.0000000000000744.</citation>
    <PMID>32044814</PMID>
  </reference>
  <reference>
    <citation>Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.</citation>
    <PMID>32091533</PMID>
  </reference>
  <reference>
    <citation>Grech V. Unknown unknowns - COVID-19 and potential global mortality. Early Hum Dev. 2020 May;144:105026. doi: 10.1016/j.earlhumdev.2020.105026. Epub 2020 Mar 31.</citation>
    <PMID>32247898</PMID>
  </reference>
  <reference>
    <citation>Goh KJ, Choong MC, Cheong EH, Kalimuddin S, Duu Wen S, Phua GC, Chan KS, Haja Mohideen S. Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from COVID-19 Infection. Ann Acad Med Singap. 2020 Mar 16;49(3):108-118.</citation>
    <PMID>32200400</PMID>
  </reference>
  <reference>
    <citation>Liu V, Kipnis P, Rizk NW, Escobar GJ. Adverse outcomes associated with delayed intensive care unit transfers in an integrated healthcare system. J Hosp Med. 2012 Mar;7(3):224-30. doi: 10.1002/jhm.964. Epub 2011 Oct 28.</citation>
    <PMID>22038879</PMID>
  </reference>
  <reference>
    <citation>Mardini L, Lipes J, Jayaraman D. Adverse outcomes associated with delayed intensive care consultation in medical and surgical inpatients. J Crit Care. 2012 Dec;27(6):688-93. doi: 10.1016/j.jcrc.2012.04.011. Epub 2012 Jun 12.</citation>
    <PMID>22699035</PMID>
  </reference>
  <reference>
    <citation>Mokart D, Lambert J, Schnell D, Fouché L, Rabbat A, Kouatchet A, Lemiale V, Vincent F, Lengliné E, Bruneel F, Pene F, Chevret S, Azoulay E. Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma. 2013 Aug;54(8):1724-9. doi: 10.3109/10428194.2012.753446. Epub 2012 Dec 26.</citation>
    <PMID>23185988</PMID>
  </reference>
  <reference>
    <citation>Cheng PK, Wong DA, Tong LK, Ip SM, Lo AC, Lau CS, Yeung EY, Lim WW. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet. 2004 May 22;363(9422):1699-700.</citation>
    <PMID>15158632</PMID>
  </reference>
  <reference>
    <citation>Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet. 2020 Mar 28;395(10229):1014-1015. doi: 10.1016/S0140-6736(20)30633-4. Epub 2020 Mar 17.</citation>
    <PMID>32197108</PMID>
  </reference>
  <reference>
    <citation>Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. J Thorac Oncol. 2020 May;15(5):700-704. doi: 10.1016/j.jtho.2020.02.010. Epub 2020 Feb 28.</citation>
    <PMID>32114094</PMID>
  </reference>
  <reference>
    <citation>Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.</citation>
    <PMID>32109013</PMID>
  </reference>
  <reference>
    <citation>Bonow RO, Fonarow GC, O'Gara PT, Yancy CW. Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. JAMA Cardiol. 2020 Jul 1;5(7):751-753. doi: 10.1001/jamacardio.2020.1105.</citation>
    <PMID>32219362</PMID>
  </reference>
  <reference>
    <citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.</citation>
    <PMID>32171076</PMID>
  </reference>
  <reference>
    <citation>Hu SB, Wong DJ, Correa A, Li N, Deng JC. Prediction of Clinical Deterioration in Hospitalized Adult Patients with Hematologic Malignancies Using a Neural Network Model. PLoS One. 2016 Aug 17;11(8):e0161401. doi: 10.1371/journal.pone.0161401. eCollection 2016.</citation>
    <PMID>27532679</PMID>
  </reference>
  <reference>
    <citation>Yancy CW. COVID-19 and African Americans. JAMA. 2020 May 19;323(19):1891-1892. doi: 10.1001/jama.2020.6548.</citation>
    <PMID>32293639</PMID>
  </reference>
  <reference>
    <citation>Izmailova ES, Wagner JA, Perakslis ED. Wearable Devices in Clinical Trials: Hype and Hypothesis. Clin Pharmacol Ther. 2018 Jul;104(1):42-52. doi: 10.1002/cpt.966. Epub 2018 Apr 2. Review.</citation>
    <PMID>29205294</PMID>
  </reference>
  <reference>
    <citation>Menta AK, Subbiah IM, Subbiah V. Bringing wearable devices into oncology practice: fitting smart technology in the clinic. Discov Med. 2018 Dec;26(145):261-270.</citation>
    <PMID>30695675</PMID>
  </reference>
  <reference>
    <citation>Ip JE. Wearable Devices for Cardiac Rhythm Diagnosis and Management. JAMA. 2019 Jan 29;321(4):337-338. doi: 10.1001/jama.2018.20437.</citation>
    <PMID>30633301</PMID>
  </reference>
  <reference>
    <citation>Shan R, Sarkar S, Martin SS. Digital health technology and mobile devices for the management of diabetes mellitus: state of the art. Diabetologia. 2019 Jun;62(6):877-887. doi: 10.1007/s00125-019-4864-7. Epub 2019 Apr 8. Review.</citation>
    <PMID>30963188</PMID>
  </reference>
  <reference>
    <citation>Radin JM, Wineinger NE, Topol EJ, Steinhubl SR. Harnessing wearable device data to improve state-level real-time surveillance of influenza-like illness in the USA: a population-based study. The Lancet Digital Health 2020;2:e85-e93</citation>
  </reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>June 2, 2020</study_first_submitted>
  <study_first_submitted_qc>June 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2020</study_first_posted>
  <last_update_submitted>August 28, 2020</last_update_submitted>
  <last_update_submitted_qc>August 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Jonathan Leff</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

